Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Effect of Fish Oil Supplementation on Hepatic and Visceral Fat in Overweight Men: A Randomized Controlled Trial.

Parker HM, Cohn JS, O'Connor HT, Garg ML, Caterson ID, George J, Johnson NA.

Nutrients. 2019 Feb 23;11(2). pii: E475. doi: 10.3390/nu11020475.

2.

Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.

Mantle D, Hargreaves I.

Antioxidants (Basel). 2019 Feb 16;8(2). pii: E44. doi: 10.3390/antiox8020044. Review.

3.

Coenzyme Q10 attenuates high-fat diet-induced non-alcoholic fatty liver disease through activation of the AMPK pathway.

Chen K, Chen X, Xue H, Zhang P, Fang W, Chen X, Ling W.

Food Funct. 2019 Feb 20;10(2):814-823. doi: 10.1039/c8fo01236a.

PMID:
30675881
4.

Idebenone and coenzyme Q10 are novel PPAR╬▒/╬│ ligands, with potential for treatment of fatty liver diseases.

Tiefenbach J, Magomedova L, Liu J, Reunov AA, Tsai R, Eappen NS, Jockusch RA, Nislow C, Cummins CL, Krause HM.

Dis Model Mech. 2018 Aug 31;11(9). pii: dmm034801. doi: 10.1242/dmm.034801.

5.

Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.

Cicero AFG, Colletti A, Bellentani S.

Nutrients. 2018 Aug 23;10(9). pii: E1153. doi: 10.3390/nu10091153.

6.

Modulatory role of Co-enzyme Q10 on methionine and choline deficient diet-induced non-alcoholic steatohepatitis (NASH) in albino rats.

Saleh DO, Ahmed RF, Amin MM.

Appl Physiol Nutr Metab. 2017 Mar;42(3):243-249. doi: 10.1139/apnm-2016-0320. Epub 2016 Nov 9.

PMID:
28177750
7.

Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.

Farsi F, Mohammadshahi M, Alavinejad P, Rezazadeh A, Zarei M, Engali KA.

J Am Coll Nutr. 2016 May-Jun;35(4):346-53. doi: 10.1080/07315724.2015.1021057. Epub 2015 Jul 9.

PMID:
26156412
8.

Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress.

Farhangi MA, Alipour B, Jafarvand E, Khoshbaten M.

Arch Med Res. 2014 Oct;45(7):589-95. doi: 10.1016/j.arcmed.2014.11.001. Epub 2014 Nov 11.

PMID:
25450583
9.

Coenzyme Q metabolism is disturbed in high fat diet-induced non-alcoholic fatty liver disease in rats.

Bravo E, Palleschi S, Rossi B, Napolitano M, Tiano L, D'Amore E, Botham KM.

Int J Mol Sci. 2012;13(2):1644-57. doi: 10.3390/ijms13021644. Epub 2012 Feb 2.

10.

Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: is there a role for dietary coenzyme Q?

Cano A, Ciaffoni F, Safwat GM, Aspichueta P, Ochoa B, Bravo E, Botham KM.

J Appl Physiol (1985). 2009 Sep;107(3):707-17. doi: 10.1152/japplphysiol.00297.2009. Epub 2009 Jul 16.

11.

Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease.

Yesilova Z, Yaman H, Oktenli C, Ozcan A, Uygun A, Cakir E, Sanisoglu SY, Erdil A, Ates Y, Aslan M, Musabak U, Erbil MK, Karaeren N, Dagalp K.

Am J Gastroenterol. 2005 Apr;100(4):850-5.

PMID:
15784031

Supplemental Content

Loading ...
Support Center